Generate a tailored SOP for Dr. Kara Maxwell. Improve your application with a focused, well-structured draft.
Kara N Maxwell, MD, PhD, is an Assistant Professor in the Department of Medicine (Hematology-Oncology) at the Perelman School of Medicine, University of Pennsylvania. She specializes in medical oncology with a focus on cancer genetics and hereditary cancer syndromes. Her research interests include familial breast and prostate cancers, exercise the determinants of disease penetrance. Dr. Maxwell is the director of the Basser Center’s Men BRCA program, actively contributing to research regarding Li Fraumeni Syndrome and its related TP53 disease-causing variants. She employs a multi-disciplinary approach, collaborating with colleagues from both basic science labs and clinical settings to explore the genetic underpinnings of cancer. Her lab, the Maxwell Lab, is dedicated to translational human genetics and genomics, studying tumor formation mechanisms in inherited cancer syndromes. Dr. Maxwell’s work is supported by prestigious funding bodies including the National Cancer Institute and the Prostate Cancer Foundation. She is a founding member of the EDISYN consortium, aimed at improving early cancer detection in patients with Li Fraumeni Syndrome. Through extensive research and collaborations, Dr. Maxwell seeks to understand the complexities of hereditary cancers and improve patient outcomes.
Perelman School of Medicine, University of Pennsylvania • Philadelphia, PA
Teaching and conducting research in Hematology-Oncology.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.